Brandinium

Trademark search for:

GANECT

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2013-11-06 — Application filed
  • 2013-12-27 — Sn assigned for sect 66a appl from ib
  • 2013-12-31 — Application filed
  • 2014-01-04 — Application filed
  • 2014-02-24 — Assigned to examiner
  • 2014-02-25 — Approved for pub - principal register
  • 2014-03-12 — Notice of publication
  • 2014-03-12 — Notification of possible opposition sent to ib
  • 2014-03-12 — Notice of start of opposition period created, to be sent to ib
  • 2014-03-28 — Notification processed by ib
  • 2014-04-01 — Published for opposition
  • 2014-06-17 — Registered-principal register
  • 2014-07-17 — Grant of protection created, to be sent to ib
  • 2014-07-18 — Final disposition recorded
  • 2014-07-18 — Final disposition recorded
  • 2014-08-07 — Notification processed by ib
  • 2020-10-23 — New representative at ib received
  • 2020-12-04 — Death of international registration
  • 2020-12-04 — Notification of effect of cancellation of intl reg mailed
  • 2021-02-19 — Final status recorded

Owner Information

Astellas Pharma Inc.
JP
Astellas Pharma Inc.
JP
Astellas Pharma Inc.
JP

Correspondent

KURODA Makoto c/o YUASA AND HARA
Section 206,
New Ohtemachi Building,
Tokyo 100-0004,

Filing Details

Filing Date:
2013-11-06
Status Date:
2021-02-19
Category:
Pharmaceuticals
Filing Year:
2013

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.